Imagen de Portada

Distribution-Based Sub-Population Selection (DSPS): A Method for in-Silico Reproduction of Clinical Trials Outcomes

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autores principales:	Ganji, Mohammadreza, Fathi, Anas El, Fabris, Chiara, Lv, Dayu, Kovatchev, Boris, Breton, Marc
Formato:	Preprint
Publicado:	2024
Materias:	Applications
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A Comparative Study of Transformer-Based Models for Multi-Horizon Blood Glucose Prediction
por: Karagoz, Meryem Altin, et al.
Publicado: (2025)

Neural Networks for on-chip Model Predictive Control: a Method to Build Optimized Training Datasets and its application to Type-1 Diabetes
por: Castillo, Alberto, et al.
Publicado: (2025)

Extending Inferences from Randomized Clinical Trials to Target Populations: A Scoping Review of Transportability Methods
por: Wang, Guanbo, et al.
Publicado: (2024)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
por: Zhang, Hong, et al.
Publicado: (2023)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
por: Thomas, Owen, et al.
Publicado: (2024)

Analyzing Population-Level Trials as N-of-1 Trials: an Application to Gait
por: Zhou, Lin, et al.
Publicado: (2022)

A Practical Analysis Procedure on Generalizing Comparative Effectiveness in the Randomized Clinical Trial to the Real-world Trialeligible Population
por: Jiang, Kuan, et al.
Publicado: (2024)

Predictive Probabilities Made Simple: A Fast and Accurate Method for Clinical Trial Decision Making
por: Marion, Joe, et al.
Publicado: (2024)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Komaki, Moka, et al.
Publicado: (2025)

Analyzing Pension Fund Mortality with Gaussian Processes in a Sub Population Framework
por: de Melo, Eduardo F. L., et al.
Publicado: (2025)

A modified modular multilevel converter to reduce the second order ripples in the submodule capacitor voltage: Design and analysis
por: Ramudu Ganji, et al.
Publicado: (2024)

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
por: Sechidis, Konstantinos, et al.
Publicado: (2024)

Regulatory Expectations for Bayesian Methods in Drug and Biologic Clinical Trials: A Practical Perspective on FDA's 2026 Draft Guidance
por: Ji, Yuan, et al.
Publicado: (2026)

Clustering-Based Outcome Models for Clinical Studies: A Scoping Review
por: Vilsmeier, Johannes, et al.
Publicado: (2026)

Use of Mobile Application for Improving Drug Compliance and Clinical Outcomes: A Randomized Controlled Trial
por: Pramod Kumar Mehta, et al.
Publicado: (2026)

Learning Smooth Populations of Parameters with Trial Heterogeneity
por: Lee, JungHo, et al.
Publicado: (2025)

Comparing Methods of Expert Elicitation for Treatment Effect or Borrowing Parameters in Standard and Rare Disease Clinical Trials: A Systematic Mapping Study
por: Morgan, Laura M., et al.
Publicado: (2025)

Covariate Adjustment for the Win Odds: Application to Cardiovascular Outcomes Trials
por: Scheidegger, Cyrill, et al.
Publicado: (2025)

Index Date Imputation For Survival Outcomes for Externally Controlled Trials
por: Coent, Q. Le, et al.
Publicado: (2025)

Signature-Informed Selection Detection: A Novel Method for Multi-Locus Temporal Population Genetic Model with Recombination
por: Dutta, Ritabrata, et al.
Publicado: (2025)

Multiple Imputation for Small, Extremely High Efficacy Clinical Trials with Binary Endpoints
por: Tan, Yaoyuan Vincent, et al.
Publicado: (2025)

Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
por: Chen, Jie, et al.
Publicado: (2024)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
por: Yang, Peng, et al.
Publicado: (2026)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
por: Phillips, Rachael V., et al.
Publicado: (2024)

Attention Networks for Personalized Mealtime Insulin Dosing in People with Type 1 Diabetes
por: Fathi, Anas El, et al.
Publicado: (2024)

Application of Markov Chains to Multiple Sclerosis Clinical Trial Data to Estimate Disease Trajectories
por: Sthanu, Uma, et al.
Publicado: (2024)

A Unified Micro-Model for Loss Reserves, IBNR and Unearned Premium Risk with Dependence, Inflation, and Discounting
por: Hamel, Emmanuel, et al.
Publicado: (2025)

Recurrent Neural Networks for Multivariate Loss Reserving and Risk Capital Analysis
por: Cai, Pengfei, et al.
Publicado: (2024)

Bringing Age Back In: Accounting for Population Age Distribution in Forecasting Migration
por: Welch, Nathan G., et al.
Publicado: (2024)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
por: Sokolova, Alexandra, et al.
Publicado: (2026)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
por: Maity, Arnab Kumar, et al.
Publicado: (2024)

Improving the Estimation of Site-Specific Effects and their Distribution in Multisite Trials
por: Lee, JoonHo, et al.
Publicado: (2023)

Consistency Assessment of Regional Treatment Effect for Multi-Regional Clinical Trials in the Presence of Covariate Shift
por: Qing, Kunhai, et al.
Publicado: (2026)

A User-Focused Approach to Evaluating Probabilistic and Categorical Forecasts
por: Loveday, Nicholas, et al.
Publicado: (2023)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
por: Lotspeich, Sarah C., et al.
Publicado: (2026)

Unified and Simple Sample Size Calculations for Individual or Cluster Randomized Trials with Skewed or Ordinal Outcomes
por: Tu, Shengxin, et al.
Publicado: (2025)

Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
por: Benz, Luke, et al.
Publicado: (2024)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
por: Zhang, Cong, et al.
Publicado: (2026)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
por: Wang, Sidi, et al.
Publicado: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
por: Sunami, Hisato, et al.
Publicado: (2024)